ENTITY
Pharmaron

Pharmaron (3759 HK)

236
Analysis
Health Care • China
Pharmaron is a premier life science service provider offering comprehensive research, development, and manufacturing services across the entire drug discovery, preclinical, clinical development, and commercialization process. The company's services encompass small molecules, biologics, and cell and gene therapy products. Pharmaron was founded in 2004 and is headquartered in Beijing, China.
more
•02 Oct 2026 09:01

HONG KONG ALPHA PORTFOLIO: (September 2026)

HK Alpha portfolio gained 2.22% in September, outperforming its benchmark by 5.36%. Since inception, the portfolio has outperformed HK indexes by...

Logo
99 Views
Share
bullish•Pharmaron
•10 Aug 2026 09:46

CHINA BIOTECH SECTOR: Pharmaron's One Stop Shop!

A US judge blocked the Defense Department from enforcing its designation of WuXi AppTec Co. as a Chinese military company, and granted...

Logo
147 Views
Share
•27 Sep 2026 16:52

Technically Speaking Breakouts & Breakdowns - HONG KONG (August 2026)

Genscript shares gain after the company announced it will provide wet-lab services to companies participating in Eli Lilly's TundeLab, helping them...

Logo
118 Views
Share
•24 Sep 2026 17:05

Technically Speaking Breakouts & Breakdowns - HONG KONG (September 2026)

The Hong Kong market continues to drift sideways this month, trading above its long-term support levels but unable to rally past strong resistance...

Logo
109 Views
Share
•01 Sep 2026 12:44

HONG KONG ALPHA PORTFOLIO: (August 2026)

HK Alpha portfolio gained 3.45% in August, outperforming its benchmark by 2.67%.  Since inception, the portfolio has outperformed HK indexes by 60%...

Logo
183 Views
Share
x